Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.
Type:
Application
Filed:
July 6, 2009
Publication date:
May 27, 2010
Applicant:
Brown Technology Partnerships
Inventors:
Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Raymond Ferri, Alison Amenta, Mary Lynn Mercado, Hiroki Hagiwara
Abstract: Transparent monolithic aerogels based on silica, the bioderived polymer chitosan, and coordinated ions are employed to serve as a three-dimensional scaffold decorated with metal ions such as Au, Pt and Pd ions. It has also been found that the metal aerogels, such as Au(III) aerogels, can be imaged photolytically to produce nanoparticles.
Type:
Grant
Filed:
November 26, 2004
Date of Patent:
July 3, 2007
Assignee:
Brown Technology Partnerships
Inventors:
William M. Risen, Jr., Xipeng Liu, Chunhua Yao, Yu Zhu